Nanoneedle Diagnostic Tool

The technology will be optimized for easy clinical adoption and scaled up so that numerous FDA-approved drugs can be simultaneously screened as potential treatments.

Severely iIl Patient

The goal of the Severely ill Patient Study was to conduct a comprehensive “Big Data” analysis on severely ill ME/CFS patients in order to begin an exploration to find the molecular basis of ME/CFS.

T cells and Immunology

The study’s objective was to establish the role of T cells and the immune system in ME/CFS by examining the genetic material in T cells — immune cells that identify and kill infected cells.